SEC Form 4 · accession 0001814943-26-000003
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. McBreen
Officer — EVP & Chief Commercial Officer
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 4:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000917520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $15.67 | Jun 1, 2026 | A | 60,372 | A | — | Jun 1, 2034 | Common Stock | 60,372 | 60,372 | D |
| Restricted Stock UnitsF2,F3 | — | Jun 1, 2026 | A | 31,909 | A | — | — | Common Stock | 31,909 | 124,017 | D |
Explanation of responses
- F1This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates.
- F2Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.